Cell line · CVCL_0504
RKO
Cancer cell line, Homo sapiens. Colon carcinoma. 153 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. RKO. Cell lines, record CVCL_0504. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0504
On this page
Cell line
As Cellosaurus gives it.
- Name
- RKO
- Accession
- CVCL_0504
- RRID
- RRID:CVCL_0504
- Species
- Homo sapiens (Human)
- Sex
- Sex unspecified
- Age at sampling
- Age unspecified
- Category
- Cancer cell line
- Diseases
- Colon carcinoma (NCIt C4910)
- Derived from
- Colon (in situ)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers153
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| PubMed 42999633 | Immunotargets Ther | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting tankyrase scaffolding in the β-catenin destruction complex by PROTAC overcomes the limitation of catalytic inhibitors in colorectal cancer. | Elife | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Integrative genomics and experimental validation identify a mechanosensitive gene signature associated with colorectal cancer liver metastasis. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| MZF1 Inhibits TGFβ-1/SMAD Signaling by Transcriptionally Activating SnoN to Augment Tumorigenic Potential in Colon Cancer. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Differential Sensitivity to xCT-inhibition by ME1 expression. | Mol Cancer Ther | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Acquired Resistance to the PRMT5 Inhibitor Confers Collateral Sensitivity to MEK Inhibition in MTAP-Null Non-Small Cell Lung Cancer. | Biomolecules | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A Novel tRNA Half mt-5'-tiRNA-Tyr Promotes Colorectal Cancer Proliferation via Inducing HARS2 Succinylation. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| CRISPR Screening Identifies SMARCAL1 and MRN as Modulators of WRN Dependency in MSI-H Colorectal Cancer. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Repurposed ethoxzolamide reprograms antitumor immunity through β-TrCP-dependent PD-L1 ubiquitination. | Cell Rep Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| RBMX promotes colorectal liver metastasis by stabilizing MTHFD2 mRNA to regulate redox homeostasis. | Cell Mol Life Sci | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 153
See all 153 papersRelatives44
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | EDITGENE RKO-CopGFP | CVCL_F6BD | Cell lines | |
| Derived from it | EDITGENE RKO-FLUC | CVCL_F5TR | Cell lines | |
| Derived from it | EcR-RKO/KLF4 | CVCL_9807 | Cell lines | |
| Derived from it | Genomeditech RKO H_AMHR2 | CVCL_E6WP | Cell lines | |
| Derived from it | HyCyte RKO KO-hPOLQ | CVCL_F4IP | Cell lines | |
| Derived from it | HyCyte RKO KO-hRNF138 | CVCL_F4JK | Cell lines | |
| Derived from it | HyCyte RKO-Luc | CVCL_E3IK | Cell lines | |
| Derived from it | RKO BRAF(+/-/-) | CVCL_HE15 | Cell lines | |
| Derived from it | RKO BRAF(V600E/+/-) | CVCL_HE16 | Cell lines | |
| Derived from it | RKO BRAF(V600E/-/-) | CVCL_HE17 | Cell lines |
1 to 10 of 44
See all 44 relativesCell banks6
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | CRL-2577 | ATCC | |
| AddexBio | C0009012/374 | Cellosaurus | |
| CLS | 305035 | CLS | |
| EDITGENE | EDC00316 | EDITGENE | |
| KCB | KCB 2011102YJ | Cellosaurus | |
| Ubigene | YC-C002 | Ubigene |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0504
GET https://conductscience.org/api/cell-lines/v1/CVCL_0504/papers?page=2